EP0918788A4 - Brca1 compositions and methods for the diagnosis and treatment of breast cancer - Google Patents

Brca1 compositions and methods for the diagnosis and treatment of breast cancer

Info

Publication number
EP0918788A4
EP0918788A4 EP97933344A EP97933344A EP0918788A4 EP 0918788 A4 EP0918788 A4 EP 0918788A4 EP 97933344 A EP97933344 A EP 97933344A EP 97933344 A EP97933344 A EP 97933344A EP 0918788 A4 EP0918788 A4 EP 0918788A4
Authority
EP
European Patent Office
Prior art keywords
brca1
diagnosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97933344A
Other languages
German (de)
French (fr)
Other versions
EP0918788A1 (en
Inventor
Wen-Hwa Lee
Yumay Chen
Chi-Fen Chen
Phang-Lang Chen
Andrew A Farmer
Diane C Jones
D Craig Allred
C Kent Osborne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of EP0918788A1 publication Critical patent/EP0918788A1/en
Publication of EP0918788A4 publication Critical patent/EP0918788A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP97933344A 1996-07-08 1997-07-08 Brca1 compositions and methods for the diagnosis and treatment of breast cancer Withdrawn EP0918788A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1586396P 1996-07-08 1996-07-08
US15863P 1996-07-08
PCT/US1997/011946 WO1998001460A1 (en) 1996-07-08 1997-07-08 Brca1 compositions and methods for the diagnosis and treatment of breast cancer

Publications (2)

Publication Number Publication Date
EP0918788A1 EP0918788A1 (en) 1999-06-02
EP0918788A4 true EP0918788A4 (en) 2002-02-13

Family

ID=21774065

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97933344A Withdrawn EP0918788A4 (en) 1996-07-08 1997-07-08 Brca1 compositions and methods for the diagnosis and treatment of breast cancer

Country Status (7)

Country Link
EP (1) EP0918788A4 (en)
JP (1) JP2002513272A (en)
KR (1) KR20000023600A (en)
AU (1) AU736210B2 (en)
CA (1) CA2259154A1 (en)
NZ (1) NZ333635A (en)
WO (1) WO1998001460A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU728352B2 (en) 1996-08-02 2001-01-04 Wistar Institute Of Anatomy And Biology, The BRCA1 associated protein (BAP-1) and uses therefor
AU7866400A (en) * 1999-10-07 2001-05-10 Baylor College Of Medicine Novel zinc finger protein
EP1399460A4 (en) * 2001-04-27 2005-04-13 Sunnybrook & Women S College H Breast cancer-associated genes and uses thereof
KR100468466B1 (en) * 2001-08-25 2005-01-27 주식회사 랩 지노믹스 Breast and ovarian cancers suseceptibility mutations of BRCA 1 and BRCA 2, and detection method using them
AU2002322199B2 (en) * 2001-09-12 2009-06-04 The Walter And Eliza Hall Institute Of Medical Research A method of diagnosis and treatment and agents useful for same
CN111253483B (en) * 2020-03-02 2021-07-30 江苏莱森生物科技研究院有限公司 anti-BRCA 1 monoclonal antibody and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US5654155A (en) * 1996-02-12 1997-08-05 Oncormed, Inc. Consensus sequence of the human BRCA1 gene
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
US5654155A (en) * 1996-02-12 1997-08-05 Oncormed, Inc. Consensus sequence of the human BRCA1 gene

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRODY L C ET AL: "Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17;MTO120 Homo sapiens genomic clone MTO120", EMBL NUCLEOTIDE SEQUENCE, XX, XX, 31 December 1994 (1994-12-31), XP002134210 *
BROWN M A ET AL: "PHYSICAL MAPPING, CLONING, AND IDENTIFICATION OF GENES WITHIN A 500-KB REGION CONTAINING BRCA1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, 1 May 1995 (1995-05-01), pages 4362 - 4366, XP002017873, ISSN: 0027-8424 *
HAKEM RAZQALLAH ET AL: "The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.", CELL, vol. 85, no. 7, 1996, pages 1009 - 1023, XP002174576, ISSN: 0092-8674 *
See also references of WO9801460A1 *
SZABO CSILLA I ET AL: "Human, canine and murine BRCA1 genes: Sequence comparison among species.", HUMAN MOLECULAR GENETICS, vol. 5, no. 9, 1996, pages 1289 - 1298, XP002174577, ISSN: 0964-6906 *

Also Published As

Publication number Publication date
WO1998001460A8 (en) 2000-01-06
AU736210B2 (en) 2001-07-26
JP2002513272A (en) 2002-05-08
NZ333635A (en) 2000-06-23
AU3655097A (en) 1998-02-02
KR20000023600A (en) 2000-04-25
CA2259154A1 (en) 1998-01-15
EP0918788A1 (en) 1999-06-02
WO1998001460A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
EP1007535A4 (en) Methods and compositions for diagnosis and treatment of breast cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU1980995A (en) Methods and compositions for treatment of breast cancer
EP0942742A4 (en) Therapeutic compositions for treatment of cancer
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL140845A0 (en) Compositions for therapy and diagnosis of prostate cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
HUP0104717A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AP9700939A0 (en) Compounds and methods for the treatment of cancer
HUP0002760A3 (en) Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
GB2318734B (en) Methods of preventing breast cancer
ZA954984B (en) Compositions and methods for the treatment of tumors
GB9811598D0 (en) Diagnosis and treatment of cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP0200825A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
EP0918788A4 (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
AU2003201293A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 21/04 A, 7C 07K 14/00 B, 7C 07K 16/00 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020103

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE ES FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20020214